About Cambrex
Cambrex is a company based in East Rutherford (United States) founded in 1981 was acquired by Permira in August 2019. The company has 46 employees as of December 31, 2022. Cambrex has completed 7 acquisitions, including Avista Pharma, Biocatalysis and Halo Pharma. Cambrex offers products and services including Custom API Development, Analytical Testing, and Formulation Development. Cambrex operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter East Rutherford, United States
- Employees 46 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cambrex Corporation
-
Annual Revenue
$532.09 M (USD)0as on Dec 31, 2018
-
Net Profit
$92.42 M (USD)-10as on Dec 31, 2018
-
EBITDA
$101.5 M (USD)-30as on Dec 31, 2018
-
Latest Funding Round
Not available
- Investors
-
Employee Count
46
as on Dec 31, 2022
-
Investments & Acquisitions
Avista Pharma
& 6 more
-
Acquired by
Permira
(Aug 07, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cambrex
Cambrex offers a comprehensive portfolio of products and services, including Custom API Development, Analytical Testing, and Formulation Development.
Offers custom development and manufacturing of pharmaceutical APIs for clinical trials.
Provides comprehensive analytical testing for drug stability and impurity identification.
Supports early-phase formulation and clinical trial manufacturing processes.
People of Cambrex
Unlock access to complete
Senior Team
24 people
Software Development Team
18 people
Leadership Team
16 people
Human Resources and Administration
12 people
Finance and Accounting
10 people
Product Management Team
8 people
Principal Team
7 people
Sales and Marketing
7 people
Unlock access to complete
Funding Insights of Cambrex
Detailed funding history for Cambrex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cambrex
Cambrex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Permira.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Locked | Locked | Locked |
Investor details for Cambrex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cambrex
Cambrex has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Avista Pharma, Biocatalysis and Halo Pharma.
Investment portfolio details for Cambrex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug development, manufacturing, and testing services are provided to clients.
|
Locked | Locked | 2015 | Locked | |
|
Drug discovery and development service provider
|
Locked | Locked | 2014 | Locked | |
|
Stability storage services for pharmaceuticals and medical devices are provided.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Cambrex
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cambrex
Detailed financials for Cambrex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cambrex Comparisons
Peer comparison for Cambrex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cambrex
Cambrex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Cambrex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cambrex
Complete news archive for Cambrex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cambrex
Cambrex was founded in 1981.
Cambrex is headquartered in East Rutherford, United States. It is registered at East Rutherford, New Jersey, United States.
As of Dec 31, 2022, the latest employee count at Cambrex is 46.
Annual revenue of Cambrex is $532.09M as on Dec 31, 2018.
Cambrex Corporation provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. They offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Their custom development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. Cambrex also develops processes to manufacture drug substances for clients use in toxicology studies, clinical studies and commercial supply. Their range of services include route selection, process and analytical development, process optimization and scale-up, safety assessments and product formulation.
Cambrex's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
Cambrex offers Custom API Development, Analytical Testing, and Formulation Development.
Cambrex has made 7 acquisitions, including Avista Pharma, Biocatalysis, and Halo Pharma.
Cambrex has 1 investor. Key investors include Permira.